Cardiac Risk Factors

LICHTEN05

This panel includes:

Homocysteine
Homocysteine has been shown to be an independent risk factor for the premature development of coronary artery disease and thrombosis. This test is intended for use in screening individuals who may be at risk for heart disease and stroke. Studies have shown that even moderate levels of homocysteine pose an increased risk for arteriosclerosis compared with the lowest 20th percentile (<7.2 mcmol/L) of population controls.

CRP
This test is used to assess risk of cardiovascular and peripheral vascular disease

Ferritin
This test is used to evaluate iron stores in the body and to determine iron deficiency anemia (hypochromic and microcytic anemias). This test can detect decreased levels found in iron deficiency anemia and increased levels found in iron overload. In hemochromatosis, both ferritin and iron saturation are increased.

Fibrinogen
This test is used primarily for detecting suspected bleeding disorders or excessive levels which could contribute to abnormal clotting. This test is also used to identify congenital afibrinogenemia, disseminated intravascular coagulation, and fibrinolytic activity.

Please Note: Individuals using oral contraceptives are found to have increased Levels.

Blood Typing [ABO grouping and Rh (D) typing]

This test is used to determine blood grouping and Rh typing. The possible blood types are: O positive, O negative, A positive, A negative, B positive, B negative, AB positive and AB negative. Type O negative is a universal donor and AB positive is a universal recipient.

APOLIPOPROTEIN A-1
LC016873

This test is used to evaluate survival rate or risk factors for individuals with myocardial infarction and peripheral vascular diseases. APO A-1 deficiency states include Tangier disease, HDL deficiency and hypoalpha-lipoprotein anemia. The apolipoprotein levels may be a better indicator of atherogenic risks than high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL).

ALPHA 1 ANTITRYPSIM (SERUM)
LC001982

This test is used to detect hereditary decreases in the production of alpha1-antitrypsin (AAT). AAT is responsible for inactivating endoproteases (protein catabolic enzymes). Decreased or nearly absent levels of AAT can be a factor in chronic obstructive lung disease and liver disease. Elevated levels can also be an indication of inflammatory states (eg, rheumatoid arthritis, bacterial infection, vasculitis, neoplasia).

Blood Typing [ABO grouping and Rh (D) typing]
LC006049

Natriuteric Peptiden
LC140889

This test is used to support the finding of congestive heart failure (CHF)

C-reactive protein (Cardiac) (High sensitivity)
LC120766

This test is used to assess risk of cardiovascular and peripheral vascular disease

CoQ10 (Coenzyme Q10)
LC120251

CoQ10 (Coenzyme Q10)

This test is used to assess blood levels of CoQ10 and will enable more precise dosing for anyone seeking to achieve and maintain high blood levels of Coenzyme Q10. CoQ10 is produced by the human body and is necessary for the basic functioning of cells. It is known to be highly concentrated in heart muscle cells due to the high energy requirements of this cell type. CoQ10 levels are reported to decrease with age and to be low in patients with some chronic diseases such as heart conditions, muscular dystrophies, Parkinson’s disease, cancer, diabetes, and HIV/AIDS. Some prescription drugs may also lower CoQ10 levels.

(ESR) Westergren Sedimentation Rate
LC005215

The ESR is a nonspecific test used to detect illness associated with acute and chronic infection, autoimmune disorders, inflammation (collagen vascular diseases), advanced neoplasm, and tissue necrosis or infarction. Elevations in fibrinogen, alpha- and beta-globulins (acute phase reactants), and immunoglobulins increase the sedimentation rate of red cells through plasma. The test is important in the detection of temporal arteritis, as well as its management.

Homocysteine
LC706994

Homocysteine has been shown to be an independent risk factor for the premature development of coronary artery disease and thrombosis. This test is intended for use in screening individuals who may be at risk for heart disease and stroke. Studies have shown that even moderate levels of homocysteine pose an increased risk for arteriosclerosis compared with the lowest 20th percentile (<7.2 mcmol/L) of population controls.

INTERKEUKIN 6 (IL-6)
This test is used to identify evaluated levels of Interleukin-6. IL-6 is a cytokine produced by many different cells including monocytes/macrophages, fibroblasts, endothelial cells, keratinocytes, mast cells, T cells and many tumor cell lines. Elevated IL-6 serum or plasma levels may occur in different conditions including sepsis, autoimmune diseases, lymphomas, AIDS, alcoholic liver disease, tumor development, Alzheimer’s disease, and in individuals with infections or transplant rejection. Elevated levels of IL-6 may be associated with an increased risk of heart attack, and stroke.

INSULIN LIKE GROWTH FACTOR BINDING PROTEIN (IGFBP-3)
LC140152

Elevated levels in hypertensive individuals have been associated with a nine-fold increase of carotid arteriosclerosis.

Interleukin-1 beta (IL-1b)
LC826027

This test is used to identify elevated levels of Interleukin-1 beta. IL-1b is a cytokine produced principally by mononuclear phagocytes but also by various other cells types including keratinocytes, epithelium and cells of the CNS. Elevated levels of Interleukin-1 beta have been implicated in sepsis, cachexia, rheumatoid arthritis, chronic myelogenous leukemia, asthma, psoriasis, inflammatory bowel disease, anorexia, AIDS, and graft-versus-host disease associated with bone marrow transplants. IL-1B is one of the key mediators of immunobiological responses to physical stress, a pilot study showed that higher levels were associated with anxiety/panic disorder. Higher than normal levels have also been associated with a significant increased risk of myocardial infarction independent of Cardio-CRP levels.

Lipoprotein (a)
LC120188

This test is used to measure excess small dense lipoprotein which is a strong indicator for premature coronary disease and atherosclerotic vascular disease, and is associated with increased risk of cardiac death in individuals with acute coronary syndromes and coronary bypass procedures.

PLAC® Test (Lp-PLA2)
LC141275

The PLAC® test aids in predicting risk for coronary heart disease, and ischemic stroke associated with atherosclerosis. The PLAC® test measures Lp-PLA2, an enzyme that promotes inflammation inside the arteries, leading to the formation of unstable, rupture-prone plaque. The PLAC® test for Lp-PLA2 is different from both cholesterol tests and other tests for inflammation because Lp-PLA2 is a specific cardiovascular risk factor that provides unique information about the stability of the plaque inside your arteries. Elevated levels of Lp-PLA2 increase your risk for heart disease and stroke since plaque rupture is the major cause of both events.

Troponin 1
LC120832

This test is used to detect cardiac injury, predict mortality in unstable cases of angina and serve as a marker for perioperative myocardial infarction.

VAP™ Test
LC804500

The VAP cholesterol test provides a more comprehensive coronary heart disease (CHD) risk assessment than the conventional Lipid Profile. Unlike the conventional lipid profile, the VAP Cholesterol test measures all primary and secondary targets of therapy. Direct measurements, not estimations, are provided for total Cholesterol, LDL, HDL, VLDL, and cholesterol subclasses.

See more Tests and Markers and Biological Terrain Assessment : Nutritional Status and Bio Terrain Assessment